{
  "doc_id": "6pn_complications_and_monitoring__4d07fd",
  "original_filename": "6PN Complications and Monitoring.pdf",
  "md_path": "data/parsed/6PN Complications and Monitoring/6PN Complications and Monitoring.md",
  "rmd_path": "data/parsed/6PN Complications and Monitoring/6PN Complications and Monitoring.rmd",
  "blocks": [
    {
      "type": "heading",
      "level": 1,
      "section": "Parenteral Nutrition (PN): Complications and Monitoring",
      "line": 0
    },
    {
      "type": "text",
      "section": "Parenteral Nutrition (PN): Complications and Monitoring",
      "line": 2,
      "preview": "--- page 1 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Overview",
      "line": 4
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 6,
      "preview": "- Cases"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 7,
      "preview": "- Complications"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 8,
      "preview": "- Nutrition excess and deficiencies"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 9,
      "preview": "- Refeeding syndrome"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 10,
      "preview": "- Metabolic bone disease (MBD)"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 11,
      "preview": "- Intestinal failure associated liver disease (IFALD)"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 12,
      "preview": "- Renal disease"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 13,
      "preview": "- Central venous access"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 14,
      "preview": "- Central line complications"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 15,
      "preview": "- Central line associated blood stream infections (CLABSIs)"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 16,
      "preview": "- Cases: review"
    },
    {
      "type": "text",
      "section": "Overview",
      "line": 18,
      "preview": "--- page 2 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Introduction",
      "line": 20
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 22,
      "preview": "- PN can be life-saving but has several complications"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 23,
      "preview": "- Metabolic"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 24,
      "preview": "- Catheter-related"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 25,
      "preview": "- Infectious"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 26,
      "preview": "- Non-infectious"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 27,
      "preview": "- Liver disease"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 28,
      "preview": "- Progress has been made to ensure PN is safer and more effective"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 29,
      "preview": "- Patients on PN require careful monitoring"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 30,
      "preview": "- Growth and anthropometric measurements"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 31,
      "preview": "- Laboratory"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 32,
      "preview": "- The practitioner must be aware of the risks of PN and be able to monitor the patients adequately"
    },
    {
      "type": "text",
      "section": "Introduction",
      "line": 34,
      "preview": "--- page 3 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Case \\#1",
      "line": 36
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 38,
      "preview": "- A 2-year-old boy with short bowel syndrome ( 70 cm of jejunum anastomosed to the transverse colon)"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 39,
      "preview": "- Copper had been removed from his PN because of the cholestasis"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 40,
      "preview": "- He presents with microcytic anemia (Hb $6.3 \\mathrm{~g} / \\mathrm{dL}$ ) requiring weekly transfus"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 41,
      "preview": "- Investigation"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 42,
      "preview": "- Abdominal ultrasound with doppler: no portal hypertension"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 43,
      "preview": "- Fecal occult blood negative"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 44,
      "preview": "- Folate, vitamin B12, vitamin E: normal"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 45,
      "preview": "- Bone marrow biopsy: changes compatible with myelodysplasia"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 46,
      "preview": "- What would you do?"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 48,
      "preview": "--- page 4 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Case \\#2",
      "line": 50
    },
    {
      "type": "text",
      "section": "Case \\#2",
      "line": 52,
      "preview": "- During a regular follow up, the parents of a 12-year-old patient on home PN mentions that she has "
    },
    {
      "type": "text",
      "section": "Case \\#2",
      "line": 53,
      "preview": "- There are no other symptoms, fever resolves spontaneously within 1 hour and they elected not to se"
    },
    {
      "type": "text",
      "section": "Case \\#2",
      "line": 54,
      "preview": "- When questioned, they mention that the episodes of fever seem to occur shortly after they connect "
    },
    {
      "type": "text",
      "section": "Case \\#2",
      "line": 55,
      "preview": "- What is your next step?"
    },
    {
      "type": "text",
      "section": "Case \\#2",
      "line": 57,
      "preview": "--- page 5 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Case #3",
      "line": 59
    },
    {
      "type": "text",
      "section": "Case #3",
      "line": 61,
      "preview": "- An 8-year-old M with short bowel syndrome on long term PN is tolerating only small amounts of elem"
    },
    {
      "type": "text",
      "section": "Case #3",
      "line": 62,
      "preview": "- Patient is on PN with SMOFlipid ${ }^{\\circledR}$ and multivitamins daily"
    },
    {
      "type": "text",
      "section": "Case #3",
      "line": 63,
      "preview": "- He receives $2 \\mathrm{mEq} / \\mathrm{kg}$ of calcium (rec: $0.5-4 \\mathrm{mEq} / \\mathrm{kg}$ ) i"
    },
    {
      "type": "text",
      "section": "Case #3",
      "line": 64,
      "preview": "- Laboratory testing yields the following results"
    },
    {
      "type": "table",
      "section": "Case #3",
      "line": 66,
      "preview": "|  - Vit A | $67 \\mathrm{mcg} / \\mathrm{dL}$ | $(26-49)$  |"
    },
    {
      "type": "table",
      "section": "Case #3",
      "line": 67,
      "preview": "| --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Case #3",
      "line": 68,
      "preview": "|  - Vit D | $18 \\mathrm{ng} / \\mathrm{dL}$ | $(30-100)$  |"
    },
    {
      "type": "table",
      "section": "Case #3",
      "line": 69,
      "preview": "|  - Vit E | $16 \\mathrm{mg} / \\mathrm{L}$ | $(4.6-14.8)$  |"
    },
    {
      "type": "table",
      "section": "Case #3",
      "line": 70,
      "preview": "|  - Calcium | $8.5 \\mathrm{mg} / \\mathrm{dL}$ | $(8.8-10.1)$  |"
    },
    {
      "type": "table",
      "section": "Case #3",
      "line": 71,
      "preview": "|  - Albumin | $2.5 \\mathrm{~g} / \\mathrm{dL}$ | $(3.8-5.4)$  |"
    },
    {
      "type": "text",
      "section": "Case #3",
      "line": 73,
      "preview": "- What adjustments do you make to his PN and supplements?"
    },
    {
      "type": "text",
      "section": "Case #3",
      "line": 75,
      "preview": "--- page 6 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 77
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 79,
      "preview": "- Caloric needs should be evaluated according to age-related requirements and adjusted to the patien"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 80,
      "preview": "- Catch-up growth"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 81,
      "preview": "- Conditions that may increase needs (surgery, chronic disease, burn, trauma etc.)"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 82,
      "preview": "- Conditions with increased losses"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 83,
      "preview": "- PN needs are generally 10-15\\% lower than EN needs"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 84,
      "preview": "- Overfeeding has been linked to PN associated liver disease"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 85,
      "preview": "- Underfeeding leads to growth failure"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 87,
      "preview": "--- page 7 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 89
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 91,
      "preview": "- Glucose"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 92,
      "preview": "- Excess glucose may cause hyperglycemia, hyperosmolarity and osmotic diuresis"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 93,
      "preview": "- Hypercarbia may also occur as well as increased risk of sepsis"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 94,
      "preview": "- Inadequate glucose infusion ( $<2 \\mathrm{mg} / \\mathrm{kg} / \\mathrm{min}$ ) may cause ketosis, s"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 95,
      "preview": "- Lipids"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 96,
      "preview": "- Excess lipids may cause hypertriglyceridemia and ketosis"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 97,
      "preview": "- Inadequate lipid provision may lead to essential fatty acid deficiency"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 98,
      "preview": "- Lipid infusion rate goal: $<0.15 \\mathrm{~g} / \\mathrm{kg} / \\mathrm{hour}$"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 100,
      "preview": "--- page 8 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 102
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 104,
      "preview": "- Glucose infusion rate (GIR) is a measure of the rate in which a patient receives intravenous dextr"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 105,
      "preview": "- Calculating GIR"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 106,
      "preview": "- Grams of carbohydrate $\\times 1000 \\div$ patient weight $(\\mathrm{kg}) \\div$ number of minutes PN "
    },
    {
      "type": "table",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 108,
      "preview": "|  Age (Years) | Goal GIR (mg/kg/min)  |"
    },
    {
      "type": "table",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 109,
      "preview": "| --- | --- |"
    },
    {
      "type": "table",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 110,
      "preview": "|  Preterm Infant | $\\sim 12$  |"
    },
    {
      "type": "table",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 111,
      "preview": "|  Term Infant | $10-14$  |"
    },
    {
      "type": "table",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 112,
      "preview": "|  Child (1-10 years) | $8-10$  |"
    },
    {
      "type": "table",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 113,
      "preview": "|  Adolescent (> 10 years) | $5-6$  |"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 115,
      "preview": "--- page 9 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 117
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 119,
      "preview": "- Electrolytes"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 120,
      "preview": "- PN should not be used to correct metabolic disturbances"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 121,
      "preview": "- Fluid output and intake should be monitored to avoid fluid overload and dehydration especially whe"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 122,
      "preview": "- Urinary sodium should be monitored in patients with excessive losses since inadequate sodium intak"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 123,
      "preview": "- Serum sodium should be between 135 and 145 mmol/L"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 124,
      "preview": "- Urinary sodium should be $>30 \\mathrm{mmol} / \\mathrm{L}$"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 126,
      "preview": "--- page 10 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 128
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 130,
      "preview": "- Trace elements"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 131,
      "preview": "- Zinc often needs to be supplemented in patients with excessive GI losses"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 132,
      "preview": "- Selenium deficiency may occur in patients on long-term PN"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 133,
      "preview": "- Chromium is a contaminant and may accumulate affecting glucose metabolism"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 134,
      "preview": "- Copper is excreted in bile and can accumulate in patients with cholestasis"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 135,
      "preview": "- Parenteral manganese has high bioavailability and is cleared through the liver, increasing the ris"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Nutrient Excess/Deficiency",
      "line": 137,
      "preview": "--- page 11 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Metabolic Complications: Refeeding Syndrome",
      "line": 139
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Refeeding Syndrome",
      "line": 141,
      "preview": "- Severe shifts in fluids and electrolytes that may occur in malnourished patients receiving artific"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Refeeding Syndrome",
      "line": 142,
      "preview": "- Manifestations include"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Refeeding Syndrome",
      "line": 143,
      "preview": "- Hypophosphoremia"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Refeeding Syndrome",
      "line": 144,
      "preview": "- Hypomagnesemia"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Refeeding Syndrome",
      "line": 145,
      "preview": "- Thiamine deficiency"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Refeeding Syndrome",
      "line": 146,
      "preview": "- Cardiac arrythmia"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Refeeding Syndrome",
      "line": 147,
      "preview": "- Hypokalemia"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Refeeding Syndrome",
      "line": 148,
      "preview": "- Hyperglycemia"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Refeeding Syndrome",
      "line": 149,
      "preview": "- Fluid overload leading to congestive heart failure and pulmonary edema"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Refeeding Syndrome",
      "line": 150,
      "preview": "- Respiratory failure"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Refeeding Syndrome",
      "line": 152,
      "preview": "--- page 12 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Management of Refeeding Syndrome",
      "line": 154
    },
    {
      "type": "text",
      "section": "Management of Refeeding Syndrome",
      "line": 156,
      "preview": "- Identification of patients at risk"
    },
    {
      "type": "text",
      "section": "Management of Refeeding Syndrome",
      "line": 157,
      "preview": "- Low BMI"
    },
    {
      "type": "text",
      "section": "Management of Refeeding Syndrome",
      "line": 158,
      "preview": "- Significant weight loss"
    },
    {
      "type": "text",
      "section": "Management of Refeeding Syndrome",
      "line": 159,
      "preview": "- Little or no nutritional intake in the past 5-10 days"
    },
    {
      "type": "text",
      "section": "Management of Refeeding Syndrome",
      "line": 160,
      "preview": "- Preexisting hypokalemia, hypophosphoremia and hypomagnesemia"
    },
    {
      "type": "text",
      "section": "Management of Refeeding Syndrome",
      "line": 161,
      "preview": "- Monitor electrolytes several times a day after initiation of PN until stable"
    },
    {
      "type": "text",
      "section": "Management of Refeeding Syndrome",
      "line": 162,
      "preview": "- Stabilize electrolytes before initiating PN"
    },
    {
      "type": "text",
      "section": "Management of Refeeding Syndrome",
      "line": 163,
      "preview": "- Start with providing 50-75\\% estimated energy needs or give current intake"
    },
    {
      "type": "text",
      "section": "Management of Refeeding Syndrome",
      "line": 164,
      "preview": "- Increase calories by 10-20\\% daily until goal reached"
    },
    {
      "type": "text",
      "section": "Management of Refeeding Syndrome",
      "line": 165,
      "preview": "- Supplement thiamine"
    },
    {
      "type": "text",
      "section": "Management of Refeeding Syndrome",
      "line": 166,
      "preview": "- Supplement phosphorus as needed"
    },
    {
      "type": "text",
      "section": "Management of Refeeding Syndrome",
      "line": 168,
      "preview": "--- page 13 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Metabolic Complications: Bone Disease",
      "line": 170
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 172,
      "preview": "- The term Metabolic Done Disease (MBD) includes several conditions including rickets, osteomalacia,"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 173,
      "preview": "- Reduction of bone mineral density may be evident before clinical signs appear"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 174,
      "preview": "- Diagnosis relies on dual-energy X-ray absorptiometry (DEXA)"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 175,
      "preview": "- Multifactorial pathogenesis"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 176,
      "preview": "- Malabsorption of Ca, Phos, Mg"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 177,
      "preview": "- Decreased physical activity"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 178,
      "preview": "- Vit D deficiency"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 179,
      "preview": "- Toxicity of some PN components such as aluminum"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 180,
      "preview": "- Underlying inflammatory condition"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 182,
      "preview": "--- page 14 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Metabolic Complications: Bone Disease",
      "line": 184
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 186,
      "preview": "- Risk higher in growth failure and longer PN duration"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 187,
      "preview": "- Possibility of MBD remains significant even when enteral autonomy is achieved"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 188,
      "preview": "- Monitoring"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 189,
      "preview": "- Annual DEXA with adequate correction for anthropometric measures"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 190,
      "preview": "- Careful evaluation of calcium balance and vitamin D"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 191,
      "preview": "- Treatment"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 192,
      "preview": "- Adequate Ca, Phos, Mg and vitamin D"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 193,
      "preview": "- Weight bearing exercise"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 194,
      "preview": "- Change medications (such as diuretics), if possible"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 195,
      "preview": "- Referral to a bone specialist and consider use of bisphosphonates"
    },
    {
      "type": "text",
      "section": "Metabolic Complications: Bone Disease",
      "line": 197,
      "preview": "--- page 15 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Complications: IFALD",
      "line": 199
    },
    {
      "type": "text",
      "section": "Complications: IFALD",
      "line": 201,
      "preview": "- Intestinal failure associated liver disease (IFALD) is a well described complication of PN"
    },
    {
      "type": "text",
      "section": "Complications: IFALD",
      "line": 202,
      "preview": "- Risk factors"
    },
    {
      "type": "text",
      "section": "Complications: IFALD",
      "line": 203,
      "preview": "- Prolonged duration of PN"
    },
    {
      "type": "text",
      "section": "Complications: IFALD",
      "line": 204,
      "preview": "- Prematurity"
    },
    {
      "type": "text",
      "section": "Complications: IFALD",
      "line": 205,
      "preview": "- Short Bowel Syndrome"
    },
    {
      "type": "text",
      "section": "Complications: IFALD",
      "line": 206,
      "preview": "- Reduced enterohepatic circulation"
    },
    {
      "type": "text",
      "section": "Complications: IFALD",
      "line": 207,
      "preview": "- Use of soybean lipid emulsion, phytosterols"
    },
    {
      "type": "text",
      "section": "Complications: IFALD",
      "line": 208,
      "preview": "- Lack of enteral feedings"
    },
    {
      "type": "text",
      "section": "Complications: IFALD",
      "line": 209,
      "preview": "- Recurrent sepsis"
    },
    {
      "type": "text",
      "section": "Complications: IFALD",
      "line": 210,
      "preview": "- Bacterial overgrowth"
    },
    {
      "type": "text",
      "section": "Complications: IFALD",
      "line": 211,
      "preview": "- Overfeeding"
    },
    {
      "type": "text",
      "section": "Complications: IFALD",
      "line": 213,
      "preview": "--- page 16 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "**Complications: IFALD**",
      "line": 215
    },
    {
      "type": "text",
      "section": "**Complications: IFALD**",
      "line": 217,
      "preview": "- Range of injury"
    },
    {
      "type": "text",
      "section": "**Complications: IFALD**",
      "line": 218,
      "preview": "- Gallstones"
    },
    {
      "type": "text",
      "section": "**Complications: IFALD**",
      "line": 219,
      "preview": "- Gallstones"
    },
    {
      "type": "text",
      "section": "**Complications: IFALD**",
      "line": 220,
      "preview": "- Cholestasis"
    },
    {
      "type": "text",
      "section": "**Complications: IFALD**",
      "line": 221,
      "preview": "- Steatosis"
    },
    {
      "type": "text",
      "section": "**Complications: IFALD**",
      "line": 222,
      "preview": "- Cirrhosis and liver failure"
    },
    {
      "type": "image",
      "section": "**Complications: IFALD**",
      "line": 224,
      "content": "![img-0.jpeg](images/b5eceaa366e31bfd.png)"
    },
    {
      "type": "image",
      "section": "**Complications: IFALD**",
      "line": 226,
      "content": "![img-1.jpeg](images/d26eea3d01739ead.png)"
    },
    {
      "type": "image",
      "section": "**Complications: IFALD**",
      "line": 228,
      "content": "![img-2.jpeg](images/80b1cda08e342fe4.png)"
    },
    {
      "type": "image",
      "section": "**Complications: IFALD**",
      "line": 230,
      "content": "![img-3.jpeg](images/cc97c7e02901645a.png)"
    },
    {
      "type": "text",
      "section": "**Complications: IFALD**",
      "line": 232,
      "preview": "--- page 17 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Complications: IFALD Management",
      "line": 234
    },
    {
      "type": "text",
      "section": "Complications: IFALD Management",
      "line": 236,
      "preview": "- Cycling PN as soon as metabolic and fluid status allows"
    },
    {
      "type": "text",
      "section": "Complications: IFALD Management",
      "line": 237,
      "preview": "- Continuous infusion of dextrose can be associated with high levels of insulin which may contribute"
    },
    {
      "type": "text",
      "section": "Complications: IFALD Management",
      "line": 238,
      "preview": "- Maximize enteral nutrition if tolerated"
    },
    {
      "type": "text",
      "section": "Complications: IFALD Management",
      "line": 239,
      "preview": "- Limit intravenous lipid emulsion (ILE) to $1 \\mathrm{~g} / \\mathrm{kg} /$ day for long-term PN if "
    },
    {
      "type": "text",
      "section": "Complications: IFALD Management",
      "line": 241,
      "preview": "--- page 18 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Complications: IFALD Management - Cont'd",
      "line": 243
    },
    {
      "type": "text",
      "section": "Complications: IFALD Management - Cont'd",
      "line": 245,
      "preview": "- Limit soybean oil ILE and use alternate lipid solution"
    },
    {
      "type": "text",
      "section": "Complications: IFALD Management - Cont'd",
      "line": 246,
      "preview": "- Pure soybean-based lipid emulsions should be avoided in the presence of cholestasis"
    },
    {
      "type": "text",
      "section": "Complications: IFALD Management - Cont'd",
      "line": 247,
      "preview": "- The use of mixed lipid emulsions may be encouraged for patients on long term PN"
    },
    {
      "type": "text",
      "section": "Complications: IFALD Management - Cont'd",
      "line": 248,
      "preview": "- Fish-oil based lipids should be considered if other strategies fail"
    },
    {
      "type": "text",
      "section": "Complications: IFALD Management - Cont'd",
      "line": 249,
      "preview": "- Treat bacterial overgrowth"
    },
    {
      "type": "text",
      "section": "Complications: IFALD Management - Cont'd",
      "line": 250,
      "preview": "- Ursodeoxycholic acid may be considered in the presence of biochemical signs of cholestasis"
    },
    {
      "type": "text",
      "section": "Complications: IFALD Management - Cont'd",
      "line": 252,
      "preview": "--- page 19 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Complications: Renal Disease",
      "line": 254
    },
    {
      "type": "text",
      "section": "Complications: Renal Disease",
      "line": 256,
      "preview": "- Renal disease in patients with SBS is multifactorial"
    },
    {
      "type": "text",
      "section": "Complications: Renal Disease",
      "line": 257,
      "preview": "- Chronic dehydration and electrolyte imbalances"
    },
    {
      "type": "text",
      "section": "Complications: Renal Disease",
      "line": 258,
      "preview": "- Recurrent sepsis"
    },
    {
      "type": "text",
      "section": "Complications: Renal Disease",
      "line": 259,
      "preview": "- Nephrocalcinosis"
    },
    {
      "type": "text",
      "section": "Complications: Renal Disease",
      "line": 260,
      "preview": "- Nephrotoxic effect of medications"
    },
    {
      "type": "text",
      "section": "Complications: Renal Disease",
      "line": 261,
      "preview": "- Management"
    },
    {
      "type": "text",
      "section": "Complications: Renal Disease",
      "line": 262,
      "preview": "- Avoidance of dehydration"
    },
    {
      "type": "text",
      "section": "Complications: Renal Disease",
      "line": 263,
      "preview": "- Regular renal ultrasound should be obtained"
    },
    {
      "type": "text",
      "section": "Complications: Renal Disease",
      "line": 264,
      "preview": "- Glomerular Filtration rate should be monitored in patients at risk"
    },
    {
      "type": "text",
      "section": "Complications: Renal Disease",
      "line": 266,
      "preview": "--- page 20 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Central Venous Access",
      "line": 268
    },
    {
      "type": "text",
      "section": "Central Venous Access",
      "line": 270,
      "preview": "- The maximum osmolarity that can be administered in a peripheral vein in $900 \\mathrm{mOsm} / \\math"
    },
    {
      "type": "text",
      "section": "Central Venous Access",
      "line": 271,
      "preview": "- The osmolarity of an intravenous solution can be calculated using the equation:"
    },
    {
      "type": "text",
      "section": "Central Venous Access",
      "line": 273,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Central Venous Access",
      "line": 274,
      "preview": "\\mathrm{mOsm} / \\mathrm{L}=(\\mathrm{AA} \\mathrm{~g} / \\mathrm{L} \\times 10)+(\\text { dextrose } \\mat"
    },
    {
      "type": "text",
      "section": "Central Venous Access",
      "line": 275,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "Central Venous Access",
      "line": 277,
      "preview": "- PN is usually administered through a central venous catheter whose tip is in the distal vena cava "
    },
    {
      "type": "text",
      "section": "Central Venous Access",
      "line": 278,
      "preview": "- Peripherally inserted central catheter (PICC line)"
    },
    {
      "type": "text",
      "section": "Central Venous Access",
      "line": 279,
      "preview": "- Tunneled cuffed central catheter (Broviac/Hickman)"
    },
    {
      "type": "text",
      "section": "Central Venous Access",
      "line": 280,
      "preview": "- Implanted port (Port-o-cath)"
    },
    {
      "type": "text",
      "section": "Central Venous Access",
      "line": 282,
      "preview": "--- page 21 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Central Line Complications: Mechanical",
      "line": 284
    },
    {
      "type": "text",
      "section": "Central Line Complications: Mechanical",
      "line": 286,
      "preview": "- Pneumo/hemothorax"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Mechanical",
      "line": 287,
      "preview": "- Hematoma"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Mechanical",
      "line": 288,
      "preview": "- Malposition"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Mechanical",
      "line": 289,
      "preview": "- Arrhythmia, perforation of the heart"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Mechanical",
      "line": 290,
      "preview": "- Non thrombotic occlusion (precipitates, kink)"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Mechanical",
      "line": 291,
      "preview": "- Extravasation of infusate into surrounding tissues"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Mechanical",
      "line": 293,
      "preview": "--- page 22 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Central Line Complications: Thrombosis",
      "line": 295
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 297,
      "preview": "- Venous thrombosis may result in loss of venous access in patients on long-term PN"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 298,
      "preview": "- Most thromboses are asymptomatic"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 299,
      "preview": "- Prevention"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 300,
      "preview": "- Adequate care of the line"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 301,
      "preview": "- Avoid drawing blood from catheter"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 302,
      "preview": "- Annual doppler ultrasound of vascular access may not detect thrombosis, consider CT or MRV"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 303,
      "preview": "- In patients on long-term PN who have lost vascular access because of a thrombus, consider prophyla"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 305,
      "preview": "--- page 23 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Central Line Complications: Thrombosis",
      "line": 307
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 309,
      "preview": "- Diagnosis"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 310,
      "preview": "- Ultrasound is non-invasive and easy to perform but may not be adequate for diagnosis of subclavian"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 311,
      "preview": "- If the ultrasound is negative and clinical suspicion is high, venography may be required for accur"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 312,
      "preview": "- Management"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 313,
      "preview": "- Thrombotic central line occlusion and central line related thrombosis require thorough investigati"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 314,
      "preview": "- Fibrinolytics such as alteplase is the drug class of choice to restore line patency of thrombus-oc"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 315,
      "preview": "- The recommended management of acute and symptomatic catheter-related thrombosis usually requires a"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Thrombosis",
      "line": 317,
      "preview": "--- page 24 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Central Line Complications: Infections / CLABSIs",
      "line": 319
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs",
      "line": 321,
      "preview": "- Central Line Associated Bloodstream Infections (CLABSIs) are a significant cause of mortality and "
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs",
      "line": 322,
      "preview": "- Incidence of CLABSI in pediatric patients is between 3.8-11.3/1000 catheter days"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs",
      "line": 323,
      "preview": "- Causes"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs",
      "line": 324,
      "preview": "- Colonization of biofilm"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs",
      "line": 325,
      "preview": "- Skin contamination"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs",
      "line": 326,
      "preview": "- Bacterial translocation"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs",
      "line": 327,
      "preview": "- Contaminated PN solution"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs",
      "line": 329,
      "preview": "--- page 25 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Central Line Complications: Infections / CLABSIs Prevention",
      "line": 331
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs Prevention",
      "line": 333,
      "preview": "- Sterile technique during placement"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs Prevention",
      "line": 334,
      "preview": "- Use line only for PN and not for blood draws"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs Prevention",
      "line": 335,
      "preview": "- Dressing changes per protocol"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs Prevention",
      "line": 336,
      "preview": "- Tubing changes for dextrose AA solutions and IV lipid"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs Prevention",
      "line": 337,
      "preview": "- Avoid multi-lumen catheters"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs Prevention",
      "line": 338,
      "preview": "- Avoid catheters in groin/diaper area"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs Prevention",
      "line": 340,
      "preview": "--- page 26 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Central Line Complications: Infections / CLABSIs - Lock Therapy",
      "line": 342
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs - Lock Therapy",
      "line": 344,
      "preview": "- Ethanol lock"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs - Lock Therapy",
      "line": 345,
      "preview": "- Significantly reduces CLABSI"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs - Lock Therapy",
      "line": 346,
      "preview": "- Concerns with precipitate formation in catheters and shortages"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs - Lock Therapy",
      "line": 347,
      "preview": "- Taurolidine lock"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs - Lock Therapy",
      "line": 348,
      "preview": "- Used mostly in Europe with good results"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs - Lock Therapy",
      "line": 349,
      "preview": "- Antibiotic lock"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs - Lock Therapy",
      "line": 350,
      "preview": "- May induces resistances to antibiotics"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs - Lock Therapy",
      "line": 351,
      "preview": "- 4\\% EDTA lock (Kite lock)"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs - Lock Therapy",
      "line": 352,
      "preview": "- Approved in Canada"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs - Lock Therapy",
      "line": 353,
      "preview": "- Non-antibiotic, anti-bacterial, anti-coagulant, anti-biofilm"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs - Lock Therapy",
      "line": 354,
      "preview": "- Significantly reduces the rate of CLABSI"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs - Lock Therapy",
      "line": 356,
      "preview": "--- page 27 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Central Line Complications: Infections / CLABSIs Management",
      "line": 358
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs Management",
      "line": 360,
      "preview": "- Any fever (>38.5) in a patient with a central line is considered a CLABSI until proven otherwise"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs Management",
      "line": 361,
      "preview": "- Blood cultures should be taken from both the CVC and a peripheral vein before starting antibiotic"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs Management",
      "line": 362,
      "preview": "- Empirical antibiotic therapy should include coverage for cutaneous as well as intestinal bacteria"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs Management",
      "line": 363,
      "preview": "- The duration of antimicrobial therapy for CLABSI with retained catheter is generally 10-14-days"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs Management",
      "line": 364,
      "preview": "- Central line should be removed if there is clinical deterioration, persisting or relapsing bactere"
    },
    {
      "type": "text",
      "section": "Central Line Complications: Infections / CLABSIs Management",
      "line": 366,
      "preview": "--- page 28 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Monitoring: Anthropometrics",
      "line": 368
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 370,
      "preview": "- Weight"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 371,
      "preview": "- Obtain naked under the age of 2 years"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 372,
      "preview": "- Children 2 years and older should be in light clothing without shoes"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 373,
      "preview": "- Length/Height"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 374,
      "preview": "- Use length board for children $\\leq 2$ years"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 375,
      "preview": "- Obtain standing height for children $>2$ years"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 376,
      "preview": "- Use adult length board or alternate measure of height for older children unable to stand"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 377,
      "preview": "- Head Circumference"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 378,
      "preview": "- Measured until 3 years of age"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 379,
      "preview": "- Mid-Upper Arm Circumference"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 380,
      "preview": "- Useful when weight skewed by fluid retention, casts or other medical devices"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 382,
      "preview": "--- page 29 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Monitoring: Anthropometrics",
      "line": 384
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 386,
      "preview": "- Physical Exam"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 387,
      "preview": "- Presence/absence of edema"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 388,
      "preview": "- Cardiac status"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 389,
      "preview": "- Liver size, jaundice"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 390,
      "preview": "- Neurologic status"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 391,
      "preview": "- Central venous catheter insertion sites"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 392,
      "preview": "- Daily Monitoring"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 393,
      "preview": "- Weight"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 394,
      "preview": "- Weekly Monitoring"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 395,
      "preview": "- Length or height"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 396,
      "preview": "- Head circumference"
    },
    {
      "type": "text",
      "section": "Monitoring: Anthropometrics",
      "line": 398,
      "preview": "--- page 30 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Monitoring: Labs and Radiology",
      "line": 400
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology",
      "line": 402,
      "preview": "- Laboratory measurements must be obtained at baseline and periodically after initiation of PN"
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology",
      "line": 403,
      "preview": "- Electrolytes, calcium, phosphorus, magnesium, blood glucose, albumin"
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology",
      "line": 404,
      "preview": "- Renal function"
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology",
      "line": 405,
      "preview": "- Liver function"
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology",
      "line": 406,
      "preview": "- Vitamins and oligoelements"
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology",
      "line": 407,
      "preview": "- Iron status"
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology",
      "line": 408,
      "preview": "- Radiological monitoring includes"
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology",
      "line": 409,
      "preview": "- Chest X-ray to assess positioning of the central line"
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology",
      "line": 410,
      "preview": "- Bone densitometry"
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology",
      "line": 411,
      "preview": "- Abdominal ultrasound"
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology",
      "line": 412,
      "preview": "- Doppler of the veins or venography"
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology",
      "line": 414,
      "preview": "--- page 31 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Monitoring: Labs and Radiology",
      "line": 416
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology",
      "line": 418,
      "preview": "|  Parameter | Initially / Hospitalized | Home PN  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology",
      "line": 419,
      "preview": "| --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology",
      "line": 420,
      "preview": "|  Electrolytes, glucose, acid-base status, triglycerides | Daily to weekly | Monthly  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology",
      "line": 421,
      "preview": "|  Calcium, phosphorus, magnesium | Twice weekly | Monthly  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology",
      "line": 422,
      "preview": "|  BUN/creatinine | Weekly | Monthly  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology",
      "line": 423,
      "preview": "|  Albumin | Weekly | Monthly  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology",
      "line": 424,
      "preview": "|  Prealbumin | Weekly | Monthly  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology",
      "line": 425,
      "preview": "|  Liver function (ALT, GGT, ALP, bilirubin) | Weekly | Monthly  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology",
      "line": 426,
      "preview": "|  Complete blood count | Weekly | Monthly  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology",
      "line": 427,
      "preview": "|  Ferritin, \\% saturation | As indicated | Monthly  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology",
      "line": 428,
      "preview": "|  PTT | As indicated | Monthly  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology",
      "line": 429,
      "preview": "|  TSH |  | Every 3 months  |"
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology",
      "line": 431,
      "preview": "--- page 32 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Monitoring: Labs and Radiology - Cont'd",
      "line": 433
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology - Cont'd",
      "line": 435,
      "preview": "|  Parameter | Initially / Hospitalized | Home PN  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology - Cont'd",
      "line": 436,
      "preview": "| --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology - Cont'd",
      "line": 437,
      "preview": "|  Trace elements ( $\\mathrm{Zn}, \\mathrm{Mn}, \\mathrm{Cu}$ and ceruloplasmin, $\\mathrm{Se}, \\mathrm"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology - Cont'd",
      "line": 438,
      "preview": "|  Vitamins (folate, B12, A, 25-OH-D, E) |  | Biannually to annually  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology - Cont'd",
      "line": 439,
      "preview": "|  Carnitine | As indicated | Biannually to annually  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology - Cont'd",
      "line": 440,
      "preview": "|  CRP | As indicated | As indicated  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology - Cont'd",
      "line": 441,
      "preview": "|  Urinary sodium | As needed if excessive losses | As needed if excessive losses  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology - Cont'd",
      "line": 442,
      "preview": "|  Liver ultrasound |  | Annually  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology - Cont'd",
      "line": 443,
      "preview": "|  Bone densitometry |  | Annually  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology - Cont'd",
      "line": 444,
      "preview": "|  Vascular ultrasound |  | Annually  |"
    },
    {
      "type": "table",
      "section": "Monitoring: Labs and Radiology - Cont'd",
      "line": 445,
      "preview": "|  Chest X-ray to assess position of central line | At placement | As needed  |"
    },
    {
      "type": "text",
      "section": "Monitoring: Labs and Radiology - Cont'd",
      "line": 447,
      "preview": "--- page 33 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Case \\#1",
      "line": 449
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 451,
      "preview": "- A 2-year-old boy with short bowel syndrome ( 70 cm of jejunum anastomosed to the transverse colon)"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 452,
      "preview": "- Copper had been removed from his PN because of the cholestasis"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 453,
      "preview": "- He presents with microcytic anemia ( $\\mathrm{Hb} 6.3 \\mathrm{~g} / \\mathrm{dL}$ ) requiring weekl"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 454,
      "preview": "- Investigation"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 455,
      "preview": "- Abdominal ultrasound with doppler: no portal hypertension"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 456,
      "preview": "- Fecal occult blood negative"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 457,
      "preview": "- Folate, vitamin B12, vitamin E: normal"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 458,
      "preview": "- Bone marrow biopsy: changes compatible with myelodysplasia"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 459,
      "preview": "- What would you do?"
    },
    {
      "type": "text",
      "section": "Case \\#1",
      "line": 461,
      "preview": "--- page 34 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Case \\#1: Review",
      "line": 463
    },
    {
      "type": "text",
      "section": "Case \\#1: Review",
      "line": 465,
      "preview": "- A 2-year-old boy with short bowel syndrome ( 70 cm of jejunum anastomosed to the transverse colon)"
    },
    {
      "type": "text",
      "section": "Case \\#1: Review",
      "line": 466,
      "preview": "- A copper level was done. Copper was nearly undetectable"
    },
    {
      "type": "text",
      "section": "Case \\#1: Review",
      "line": 467,
      "preview": "- Copper was added to PN and anemia, thrombocytopenia, and leucopenia resolved"
    },
    {
      "type": "text",
      "section": "Case \\#1: Review",
      "line": 468,
      "preview": "- In case of copper deficiency, finds on bone marrow may mimic myelodysplastic syndrome"
    },
    {
      "type": "text",
      "section": "Case \\#1: Review",
      "line": 469,
      "preview": "- Abdominal ultrasound with doppler: no portal hypertension"
    },
    {
      "type": "text",
      "section": "Case \\#1: Review",
      "line": 470,
      "preview": "- Fecal occult blood negative"
    },
    {
      "type": "text",
      "section": "Case \\#1: Review",
      "line": 471,
      "preview": "- Folate, vitamin B12, vitamin E: normal"
    },
    {
      "type": "text",
      "section": "Case \\#1: Review",
      "line": 472,
      "preview": "- Bone marrow biopsy: changes compatible with myelodysplasia"
    },
    {
      "type": "text",
      "section": "Case \\#1: Review",
      "line": 473,
      "preview": "- What would you do?"
    },
    {
      "type": "text",
      "section": "Case \\#1: Review",
      "line": 475,
      "preview": "--- page 35 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Case \\#2",
      "line": 477
    },
    {
      "type": "text",
      "section": "Case \\#2",
      "line": 479,
      "preview": "- During a regular follow up, the parents of a 12-year-old patient on home parenteral nutrition ment"
    },
    {
      "type": "text",
      "section": "Case \\#2",
      "line": 480,
      "preview": "- There are no other symptoms, fever resolves spontaneously within 1 hour and they elected not to se"
    },
    {
      "type": "text",
      "section": "Case \\#2",
      "line": 481,
      "preview": "- When questioned, they mention that the episodes of fever seem to occur shortly after they connect "
    },
    {
      "type": "text",
      "section": "Case \\#2",
      "line": 482,
      "preview": "- What is your next step?"
    },
    {
      "type": "text",
      "section": "Case \\#2",
      "line": 484,
      "preview": "--- page 36 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Case \\#2: Review",
      "line": 486
    },
    {
      "type": "text",
      "section": "Case \\#2: Review",
      "line": 488,
      "preview": "- During a cardiac follow up, the parents of a 12-year-old patient on some part - A blood culture wa"
    },
    {
      "type": "text",
      "section": "Case \\#2: Review",
      "line": 489,
      "preview": "- Peripheral vein: negative"
    },
    {
      "type": "text",
      "section": "Case \\#2: Review",
      "line": 490,
      "preview": "- The patient may detach and cause spikes of fever"
    },
    {
      "type": "text",
      "section": "Case \\#2: Review",
      "line": 491,
      "preview": "- A high index of suspicion is necessary when it comes to fever in a patient with a central line"
    },
    {
      "type": "text",
      "section": "Case \\#2: Review",
      "line": 492,
      "preview": "- The patient was admitted and treated with anti-fungal and the central line was replaced"
    },
    {
      "type": "text",
      "section": "Case \\#2: Review",
      "line": 494,
      "preview": "--- page 37 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Case #3",
      "line": 496
    },
    {
      "type": "text",
      "section": "Case #3",
      "line": 498,
      "preview": "- An 8-year-old M with short bowel syndrome on long term PN is tolerating only small amounts of elem"
    },
    {
      "type": "text",
      "section": "Case #3",
      "line": 499,
      "preview": "- Patient is on PN with SMOFlipid ${ }^{\\circledR}$ and multivitamins daily"
    },
    {
      "type": "text",
      "section": "Case #3",
      "line": 500,
      "preview": "- He receives $2 \\mathrm{mEq} / \\mathrm{kg}$ of calcium (rec: $0.5-4 \\mathrm{mEq} / \\mathrm{kg}$ ) i"
    },
    {
      "type": "text",
      "section": "Case #3",
      "line": 501,
      "preview": "- Laboratory testing yields the following results"
    },
    {
      "type": "table",
      "section": "Case #3",
      "line": 503,
      "preview": "|  - Vit A | $67 \\mathrm{mcg} / \\mathrm{dL}$ | $(26-49)$  |"
    },
    {
      "type": "table",
      "section": "Case #3",
      "line": 504,
      "preview": "| --- | --- | --- |"
    },
    {
      "type": "table",
      "section": "Case #3",
      "line": 505,
      "preview": "|  - Vit D | $18 \\mathrm{ng} / \\mathrm{dL}$ | $(30-100)$  |"
    },
    {
      "type": "table",
      "section": "Case #3",
      "line": 506,
      "preview": "|  - Vit E | $16 \\mathrm{mg} / \\mathrm{L}$ | $(4.6-14.8)$  |"
    },
    {
      "type": "table",
      "section": "Case #3",
      "line": 507,
      "preview": "|  - Calcium | $8.5 \\mathrm{mg} / \\mathrm{dL}$ | $(8.8-10.1)$  |"
    },
    {
      "type": "table",
      "section": "Case #3",
      "line": 508,
      "preview": "|  - Albumin | $2.5 \\mathrm{~g} / \\mathrm{dL}$ | $(3.8-5.4)$  |"
    },
    {
      "type": "text",
      "section": "Case #3",
      "line": 510,
      "preview": "- What adjustments do you make to his PN and supplements?"
    },
    {
      "type": "text",
      "section": "Case #3",
      "line": 512,
      "preview": "--- page 38 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Case \\#3: Review",
      "line": 514
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 516,
      "preview": "- A Interventions"
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 517,
      "preview": "- Vit A"
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 518,
      "preview": "- Vit A toxicity leads to complications including liver damage"
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 519,
      "preview": "- Plan: Decrease parenteral MVI to 3 days/week and recheck level in 3 months."
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 520,
      "preview": "- Vit D"
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 521,
      "preview": "- B"
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 522,
      "preview": "- Begin $75 \\mathrm{IU} / \\mathrm{kg}$ vitamin D enterally or as dissolvable quick melt."
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 523,
      "preview": "- Vit E"
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 524,
      "preview": "- Elevated levels are common with patients on SMOF."
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 525,
      "preview": "- Decreasing MVI to 3 days/week will address elevated vit E."
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 526,
      "preview": "- Calcium"
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 527,
      "preview": "- Correct calcium for low albumin."
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 528,
      "preview": "- Equation $=0.8(4(\\mathrm{nl}$ albumin $)-2.5$ (pt's albumin $))=1.2+8.5$ (serum Ca) $=9.7$."
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 529,
      "preview": "- Pt's Ca dose is within rec'd range. Corrected level is normal. No intervention required."
    },
    {
      "type": "text",
      "section": "Case \\#3: Review",
      "line": 531,
      "preview": "--- page 39 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Conclusion",
      "line": 533
    },
    {
      "type": "text",
      "section": "Conclusion",
      "line": 535,
      "preview": "- A multidisciplinary team should be involved in the initiation and the follow up of patients on PN"
    },
    {
      "type": "text",
      "section": "Conclusion",
      "line": 536,
      "preview": "- Physician"
    },
    {
      "type": "text",
      "section": "Conclusion",
      "line": 537,
      "preview": "- Dietitian"
    },
    {
      "type": "text",
      "section": "Conclusion",
      "line": 538,
      "preview": "- Nurse"
    },
    {
      "type": "text",
      "section": "Conclusion",
      "line": 539,
      "preview": "- Pharmacist"
    },
    {
      "type": "text",
      "section": "Conclusion",
      "line": 540,
      "preview": "- Surgeon"
    },
    {
      "type": "text",
      "section": "Conclusion",
      "line": 541,
      "preview": "- Interventional radiologist"
    },
    {
      "type": "text",
      "section": "Conclusion",
      "line": 542,
      "preview": "- With adequate monitoring PN can be administered safely and complications can be minimized"
    }
  ],
  "images": [
    {
      "sha_name": "b5eceaa366e31bfd.png",
      "original_ref": "img-0.jpeg",
      "page": 16,
      "relative_path": "images/b5eceaa366e31bfd.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/6PN Complications and Monitoring/images/b5eceaa366e31bfd.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "b5eceaa366e31bfd"
    },
    {
      "sha_name": "d26eea3d01739ead.png",
      "original_ref": "img-1.jpeg",
      "page": 16,
      "relative_path": "images/d26eea3d01739ead.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/6PN Complications and Monitoring/images/d26eea3d01739ead.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "d26eea3d01739ead"
    },
    {
      "sha_name": "80b1cda08e342fe4.png",
      "original_ref": "img-2.jpeg",
      "page": 16,
      "relative_path": "images/80b1cda08e342fe4.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/6PN Complications and Monitoring/images/80b1cda08e342fe4.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "80b1cda08e342fe4"
    },
    {
      "sha_name": "cc97c7e02901645a.png",
      "original_ref": "img-3.jpeg",
      "page": 16,
      "relative_path": "images/cc97c7e02901645a.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/6PN Complications and Monitoring/images/cc97c7e02901645a.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "cc97c7e02901645a"
    }
  ],
  "extraction": {
    "ocr_model": "mistral-ocr-latest",
    "request_id": "local-1754696126",
    "ts": "2025-08-08T23:35:26.118235+00:00"
  }
}